TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | -4 | -6 | -26 | -46 | -63 | -24 |
| P | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 | |||
| S | %ret | 1 | 1 | 1 | 0 | 0 | -9 | 36 | 1 | -17 | 3 |
| S | %wins | 100 | 100 | 100 | 0 | 0 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/9/06 16:21 | 12/15/05 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazarus J Michael Md | PA | D | M.d | 38 | 3.75 | 19 | 10 | 519 | 12 | D | -33 | 31 | 303 | 82 | 28 | -9 | -1 | 3 | 0 | 0 | -9 | 36 | 1 | -17 | |
1/9/06 16:21 | 12/15/05 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazarus J Michael Md | PA | D | S.d | -44 | 4.40 | 19 | -10 | -46 | 12 | D | -33 | 31 | 303 | 82 | 28 | -9 | -1 | 3 | 0 | 0 | -9 | 36 | 1 | -17 | |
3/3/04 11:05 | 8/22/01 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazarus J Michael Md | MA | D | P.m | 11 | 5.77 | 1 | 2 | 19 | 12 | D | -38 | 45 | 2 | 8 | 1 | -1 | -3 | -2 | 2 | -4 | -6 | -26 | -46 | -63 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |